Pangene Corporation Launches DirectGenomics.com, a One-Stop Genomics Portal To Genomic Services
(PR Newswire)...Pangene utilized the services provided by DirectGenomics for its own development of a pipeline of biovalidated pharmaceutical drugs for DNA repair enzymes that are dysregulated in tumors.......RRPDS are conveniently formulated for use in combination with conventional cancer therapies for more effective treatments of chemotherapeutic drug resistant and radiation resistant skin, breast, ovarian, colon, brain, prostate, pancreatic, head and neck and other tumors....- May 21 8:07 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010521/sfm081.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines